Particle.news

Mitochondrial Map and Reannotated Genome Reveal How Acanthamoeba Survives Low Oxygen

The datasets offer a road map to selectively target Acanthamoeba mitochondria to reduce toxicity of current treatments.

Overview

  • The two papers, published Oct. 1–2, 2026 as part of the MitoCarta Tree of Life Consortium, raised Acanthamoeba nuclear genome annotation accuracy from about 52% to 98% and annotated roughly 16,000 genes.
  • Researchers produced AcMitoCarta, an experimentally defined mitochondrial proteome of 1,122 proteins built from purified mitochondria, mass spectrometry, protein-correlation profiling, and complexome analysis.
  • Proteomic and transcriptomic data show the amoeba rewires mitochondrial bioenergetics by oxygen level and uses a mitochondria-localized, oxygen-sensitive hydrogenase to make hydrogen gas under anoxia.
  • About 300–381 mitochondrial proteins lack clear human or yeast counterparts, giving priority candidates for microbe-specific diagnostics or drugs that would be less toxic to human cells.
  • Authors say the resource is a starting point for focused functional tests of essential proteins, studies of cyst formation and oxygen adaptation, and longer-term drug discovery rather than an immediate therapy.